|
HS Code |
896837 |
| Iupac Name | 4-[2-[(3-ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide |
| Molecular Formula | C16H21N3O4S |
| Molecular Weight | 351.43 g/mol |
| Cas Number | 153253-63-7 |
| Appearance | White to off-white solid |
| Solubility | Soluble in DMSO and methanol |
| Storage Temperature | Store at -20°C |
| Purity | Typically ≥98% |
| Synonyms | L-685,458 derivative |
As an accredited 4-[2-[(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolin-1-Yl)Carboxamido]Ethyl]Benzenesulfonamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White HDPE bottle with blue screw cap, labeled with compound name and hazard details; contains 25 grams of 4-[2-[(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolin-1-Yl)Carboxamido]Ethyl]Benzenesulfonamide. |
| Shipping | This chemical, 4-[2-[(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolin-1-Yl)Carboxamido]Ethyl]Benzenesulfonamide, is shipped in tightly sealed containers, protected from moisture, heat, and light. It is transported according to standard regulations for non-hazardous laboratory chemicals, with clear labeling and safety documentation provided. Delivery typically occurs via trusted courier or freight services. |
| Storage | Store 4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible substances such as strong oxidizers. Ensure appropriate labeling and access control, and follow all applicable safety guidelines and local regulations for chemical storage. |
Applications of 4-[2-[(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolin-1-Yl)Carboxamido]Ethyl]Benzenesulfonamide in Industrial ManufacturingAs the direct producer of 4-[2-[(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolin-1-Yl)Carboxamido]Ethyl]Benzenesulfonamide, we supply this advanced sulfonamide derivative to high-value segments. Our partners in pharmaceuticals, agrochemicals, specialty coatings, and diagnostic products rely on our controlled manufacturing and traceable batch production for downstream formulation consistency and regulatory compliance. 1. Active Pharmaceutical Ingredient (API) Synthesis for Antihypertensive DrugsSeveral pharmaceutical manufacturers select this compound as a key sulfonamide intermediate for producing non-peptide angiotensin receptor blocker APIs. The amide linkage and sulfonamide moiety permit direct integration into synthetic routes for antihypertensive drugs. The material’s precise purity and particle size facilitate robust, reproducible condensation and cyclization steps in process reactors, especially under nitrogen. Consistency in this intermediate ensures downstream processes meet GMP thresholds for APIs targeting regulated markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Herbicide Intermediate ProductionLeading crop protection chemical manufacturers employ this compound as a coupling intermediate when creating specific sulfonylurea and sulfonamide herbicide actives. The benzene sulfonamide backbone supports subsequent fusion with heterocyclic rings in multi-step synthesis for high-performance systemic herbicides. Strict in-process trace metal controls are essential, as downstream toxicity profiles for agricultural use require minimized heavy metal and anion contamination. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fluorescent Diagnostic Marker SynthesisManufacturers of biochemistry and analytical reagents utilize this compound as a foundation for synthesizing sulfonamide-linked fluorophores. Its aromatic sulfonamide group enables stable conjugation to reporter molecules through carboxamide-functionalized linkers in organic synthesis. High-purity batches ensure minimal background signal, supporting sensitive downstream diagnostic assays for laboratory automation and clinical chemistry. Controlled handling prevents batch-to-batch variation critical for quantitative fluorescence applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Functional Monomer Sourcing for Medical Polymeric CoatingsMedical device coating formulators source this material as a niche sulfonamide monomer for synthesizing polymerizable medical coatings. The compound’s sulfonamide and amide groups add hydrophilicity and chemical resistance to polyacrylamide-based coatings, suitable for catheters and stents. Production must strictly monitor residual solvents and unreacted monomer content to comply with FDA device biocompatibility requirements. Routine analysis ensures batch uniformity for coating application lines in ISO 8 clean rooms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Intermediate for Specialty Reactive Dyes ManufacturingProducers of specialty reactive dyes deploy this material as a selective nucleophile for attaching sulfonamide chromophores to molecular frameworks targeting high-uptake textile dyes. Its carboxamide functional group behaves as a linker during diazotization and coupling stages, facilitating attachment to triazine or vinyl sulfone anchors. Consistency in functional group integrity secures reproducibility in shade development and wash fastness after batch dyeing processes for technical textiles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-[2-[(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolin-1-Yl)Carboxamido]Ethyl]Benzenesulfonamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working from the ground up in chemical manufacturing, we’ve learned to keep our focus tight. Consistency, reliability, and product traceability anchor everything we do. These principles guide the way we produce 4-[2-[(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolin-1-Yl)Carboxamido]Ethyl]Benzenesulfonamide (sometimes known among development chemists as a functionalized benzenesulfonamide derivative). Experience in plant process control and fine organic synthesis confirms that no two lots come out the same without adjusting for raw material purity, humidity, reactor temperature, and workup sequence. We have tuned our operation over countless batches — keeping moisture content, impurity profiles, and bulk density firmly within set range so research chemists and formulators know precisely what ends up in their process.
Quality rests on trust. We lay out our specifications directly and concisely, cutting through the fluff. Our standard model for this compound aims for more than 98% HPLC purity with consistent color, often a faint off-white powder. Water content stays under 0.5%—a metric made possible by in-line moisture analysis and rigorous packaging. Because sulfonamide derivatives can be sensitive to light and air, we seal our material under inert gas and package in high-barrier containers right at the discharge port. We don’t cut corners by running old drum stocks or offering blends to mask inconsistencies.
This compound finds its roots at the intersection of medicinal chemistry and advanced materials science. Its structure—a benzenesulfonamide core appended by a carboxamidoethyl bridge and a substituted pyrrolinone—offers functional groups chemists value for building bioactive molecules, screening for enzyme inhibition, and even exploring selective receptor modulations. Our customers in pharma research lean on this specific template in exploratory SAR programs thanks to its balanced lipophilicity and hydrogen bond donor/acceptor profile.
What often sets this compound apart is its ability to thread a needle between water solubility and cell membrane permeability. The ethyl and methyl substitutions on the pyrrolinone alter the overall polarity, leading to unique partition coefficients. In hands-on testing, scientists have achieved clean, reproducible crystallization during salt formation, often achieving dosage forms with consistent particle size distributions. Rather than relying solely on theory, we took product aliquots through routine forced degradation, showing resistance to ambient hydrolysis and limited uptake of ambient moisture. For end-users, this offers a baseline of stability sorely needed for multi-step syntheses or for carrying a reactive functional group forward.
Years in the reactor hall have shown us where the bottlenecks happen: incomplete cyclization, lingering aromatic byproducts, or variable yields from fluctuating raw material purity. To address these, we designed our line with segmented reaction zones and implemented continuous feed of critical starting materials. Real-world time pressure in scale-up moved us to set up at-line NMR analysis, so we now catch incomplete couplings within minutes instead of hours into a batch. That’s the only way to cut waste and avoid rework, two major headaches in specialty chemical production.
We’re not just filling orders; we’re troubleshooting with customers. Small differences in impurity content can skew an entire medchem project. A spike in a regioisomer or low-level sulfinic acid residues might derail an API campaign or cause anomalies in high-throughput screening. Because we run quality checks with knowledge gained from past process hiccups, we reduce batch-to-batch drift. It’s not unusual for a customer to call up our technical head directly, sharing spectra or asking for root-cause analysis. Our open lines of communication stretch from bench to shipping dock.
We’ve seen the market fill with resellers and opportunistic traders peddling bulk lots. Their profit comes from offloading excess, sometimes blended with lower-grade intermediates or poorly filtered end-products. Our approach couldn’t be more different—we manufacture freshly and document every stage from raw material QC through final filtration and pack-out. Analytical transparency means that users aren’t left guessing about lot contaminants or downstream stability. For R&D labs, that difference can mean a successful scale-up, fewer failed assays, or a clear path to clinical candidate nomination.
Some producers staple on generic certificates of analysis, often recycling data between batches. Our output never leaves the site without a batch-specific HPLC, NMR, and even trace metal profile. We maintain archived samples so customers who discover analytical challenges six or eighteen months later can always request a cross-check. Reliability like this takes extra overhead and man-hours, but the long-term trust it generates is indispensable.
Initial pilot amounts, produced on glassware, often looked pure by TLC and melting point, but real-world scale-up exposed bottlenecks. Incorrect mixing speeds led to partial precipitation, requiring more aggressive dilution and running up solvent costs. We learned to control stoichiometry tightly and have redesigned our agitation step to handle the shifting viscosity of the developing pyrrolinone ring. Decades working with nitrogenous heterocycles convinced us never to shortcut the phase separation and drying steps, so our end-users never waste time removing stubborn residues with extended recrystallization.
Process tweaks, learned from lab to pilot, enabled us to launch our first 10 kg campaign with complete analytics. From scale-up onwards, we witnessed a drop in solvent waste by 33% and a boost in isolated yield — achievements born from tuning, not from luck. Designing these improvements means our product performs identically in 100-gram R&D lots and multi-kilogram production, giving researchers and manufacturers a sense of confidence throughout the product lifecycle.
Providing a sulfonamide derivative goes beyond synthesizing and packing. Our partners depend on expertise built through seeing these molecules’ quirks play out in live projects. Questions come in regularly from research labs: will the benzenesulfonamide group impact their resin-coupling result, or can they apply typical amide bond-forming chemistry without risking breakdown? Our technical staff draws on years handling this scaffold to offer targeted recommendations. For difficult cases, we’ve advised on appropriateness in late-stage formylation and even supported patent filings, referencing the unique N-alkyl substitution pattern.
Customers in high-throughput screening environments have told us this compound’s purity and handling properties cut screening times due to more uniform dissolution — in practice, fewer microplate failures and less operator oversight. That feedback cycles back to us, driving further refinements in drying, sieving, and micronization steps. We still run occasional small-lot experiments to test changes before rolling them into wider production. Continuous improvement isn’t just a slogan for third-party audits; it is our approach to staying relevant in a fast-changing discovery landscape.
Having worked through numerous GHS revisions, REACH registrations, and changes in U.S. and Asian chemical control lists, we keep our documentation current and accessible. Out-of-date safety sheets or vague hazard classifications lead to shipment delays and customer headaches. With every product lot, we supply complete hazard communication, up-to-date toxicological data, and guidance for safe handling. It’s not only about checking regulatory boxes; it’s about minimizing risks to research chemists and logistics teams alike.
Our production includes in-built environmental controls to minimize emissions and ensure proper disposal. We treat waste streams at-source, separating amide-bearing filtrates from sulfonic fraction, reducing incident rates for downstream operators. Since inception, we’ve recorded no major handling accidents tied to this compound, evidence of effective process design and upstream hazard anticipation.
Inevitably, challenges arise. Clients in different global regions face supply chain disruptions or evolving regulatory rules, especially as countries restrict certain amine sources or pyrrolinone intermediates. Our logistics team works with freight forwarders and customs experts to minimize landed cost surprises and to clarify import codes. We’ve helped partner labs combat unique issues—from static charge build-up during sieving in dry climates, to customs misclassification in emerging markets.
Problems with batch homogeneity show up fast in production lines using downstream granulation or fine powder filling. We see it in action when a customer’s fill-rate drops or capsule testing flags micro-scale agglomerates. Drawing on prior headaches, we now stage particle size checks and blend uniformity tests in parallel with purity analysis, sending out only lots proven to meet vertical filling demands. Sharing solutions—whether it’s a modified sieve size or improved anti-caking flow agent—keeps our customers running.
Feedback from process chemists often points to problems months before they appear in documentation or specifications. Recently, a partner highlighted minor off-flavors during sensory testing, traced back to residual pyrrolidine content. We ran in-house GC-MS analyses, pinpointed a reaction stage where incomplete imide formation occurred, and swapped out a problematic workup solvent. By closing that loop quickly, we averted broader issues and protected the integrity of customer projects.
A close relationship with client QC teams unearths subtle issues overlooked by less-involved manufacturers. For example, trace sodium contamination from rinse-water wasn’t flagged by previous specs but affected microcrystal formation in a biopharma fill operation. Within weeks, we incorporated a final wash in deionized water and saw the problem fall off. Stories like this underline our ongoing commitment to open technical dialogue, not just transactional sales.
Many labs source rare building blocks from whichever vendor lists a CAS number online. That method quickly falls apart as scale or scrutiny increases. Inconsistent supply, spotty analytics, and lack of technical engagement wear thin quickly. As a true manufacturer, owning the process from raw chemistry to branded pack-out, we give our users a consistent, document-backed foundation for R&D and early-stage production.
We know researchers expect not only material delivery but also actionable support—help troubleshooting solubility, integrating our compound into new synthetic routes, or providing spectral review. Every order, regardless of size, carries that same expectation. To keep pace, we document improvements learned through both laboratory innovation and plant-level troubleshooting, setting us apart from risk-averse brokers focused only on margin.
Value means much more than price per kilogram. For advanced chemical intermediates like 4-[2-[(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolin-1-Yl)Carboxamido]Ethyl]Benzenesulfonamide, reproducibility, purity, and supplier know-how bring lasting gains downstream. Synthetic chemists and process engineers lean on those details at every stage—avoiding failed reactions, reducing clean-up, and keeping data integrity intact.
In-house experience has taught us not to shortcut development. Upfront investments in process R&D enable us to match customer demands as projects scale, while reliable analytics ensure long-term project clarity. Continued production – batch by batch – cements our reputation as a go-to partner for researchers who simply cannot risk uncertainty or variable handling in their supply chain.
Every lot of 4-[2-[(3-Ethyl-4-Methyl-2-Oxo-3-Pyrrolin-1-Yl)Carboxamido]Ethyl]Benzenesulfonamide we send out carries the weight of experience and the pride of being a true manufacturer. Customers taking novel molecules from benchtop to patent application want assurance—assurance that their material reflects honest work, thoughtful process control, and the kind of shared experience only direct manufacturers can offer.
In an environment where trust is built batch by batch, through consistent technical partnership and ongoing transparency, only a manufacturer deeply rooted in its own process can rise above the field. That’s how we built our reputation—and how we continue to keep customers moving forward, project after project.